Cannabis Haze: UK Faces Mental Health Crisis?

The increasing prevalence of cannabis use across the UK is raising significant mental health concerns, with experts warning of a potential crisis. The potency of cannabis, particularly the skunk strain, has dramatically increased over decades, now containing up to 20% THC, compared to 2% in the 1960s. This rise in THC levels, coupled with a decrease in protective CBD, is strongly associated with a surge in cannabis-induced psychosis.

Psychiatrists report a significant increase in patients presenting with acute psychotic episodes, a severe mental health condition characterized by delusions and hallucinations. Research indicates that earlier and more frequent cannabis use heightens the risk of developing psychosis, with potential long-term or even lifelong effects. Studies suggest regular use can permanently alter brain structure, increasing the risk of psychotic and bipolar disorders, particularly in adolescents.

The growth of private clinics prescribing 'medical' cannabis is also under scrutiny. These clinics often dispense high-THC formulations, similar to street-level skunk, which critics fear legitimize recreational use and may be inadvertently supplying individuals seeking non-medical benefits. This trend is mirrored in countries like Germany, Portugal, and Canada, where legalisation or medical sanctioning has been followed by documented increases in psychosis-related emergency treatments and schizophrenia cases.

While some advocate for cannabis's therapeutic potential, citing its mild use for pain, concerns persist that the medicalisation of cannabis could mislead the public about the safety of illegal cannabis. The potential for lifelong mental health issues, coupled with risks of stroke, foetal abnormalities, and other physical ailments, underscores the urgent need for careful consideration of cannabis policy in the UK.